Found: 98
Select item for more details and to access through your institution.
Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics.
- Published in:
- Prostate, 1998, v. 34, n. 4, p. 259, doi. 10.1002/(SICI)1097-0045(19980301)34:4<259::AID-PROS3>3.0.CO;2-C
- By:
- Publication type:
- Article
Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7565, doi. 10.1007/s00432-023-04678-2
- By:
- Publication type:
- Article
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5591, doi. 10.1007/s00432-022-04512-1
- By:
- Publication type:
- Article
The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2427, doi. 10.1007/s00432-021-03781-6
- By:
- Publication type:
- Article
Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 3, p. 256
- By:
- Publication type:
- Article
Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/4659062
- By:
- Publication type:
- Article
Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0617-1
- By:
- Publication type:
- Article
Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel.
- Published in:
- Liver International, 2014, v. 34, n. 2, p. 174, doi. 10.1111/liv.12314
- By:
- Publication type:
- Article
Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2013, v. 33, n. 6, p. 950, doi. 10.1111/liv.12168
- By:
- Publication type:
- Article
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma ( EPOIHCC).
- Published in:
- Liver International, 2013, v. 33, n. 3, p. 327, doi. 10.1111/liv.12083
- By:
- Publication type:
- Article
The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113266
- By:
- Publication type:
- Article
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4197, doi. 10.1245/s10434-022-11592-3
- By:
- Publication type:
- Article
ASO Visual Abstract: Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, n. 12, p. 3747, doi. 10.1245/s10434-013-3070-y
- By:
- Publication type:
- Article
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.
- Published in:
- Nature Medicine, 2013, v. 19, n. 3, p. 329, doi. 10.1038/nm.3089
- By:
- Publication type:
- Article
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 1, p. 61, doi. 10.1111/ajco.12465
- By:
- Publication type:
- Article
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 567, doi. 10.1007/s10637-018-0707-5
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2009, v. 24, n. 11, p. 1311, doi. 10.1007/s00384-009-0758-3
- By:
- Publication type:
- Article
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992992
- By:
- Publication type:
- Article
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921992992
- By:
- Publication type:
- Article
Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, p. 1, doi. 10.1177/1758835920965842
- By:
- Publication type:
- Article
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920926796
- By:
- Publication type:
- Article
Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0090133
- By:
- Publication type:
- Article
A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1593, doi. 10.1007/s00262-020-02794-3
- By:
- Publication type:
- Article
5-Fluorouracil, Mitomycin-C, and Polysaccharide-K versus Uracil-Ftorafur and Polysaccharide-K as Adjuvant Chemoimmunotherapy for Patients with Locally Advanced Gastric Cancer with Curative Resection.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 7/8, p. 421, doi. 10.1159/000349957
- By:
- Publication type:
- Article
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2969, doi. 10.3390/cancers16172969
- By:
- Publication type:
- Article
Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2395, doi. 10.3390/cancers12092395
- By:
- Publication type:
- Article
Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2022, v. 42, n. 3, p. 674, doi. 10.1111/liv.15102
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573
- By:
- Publication type:
- Article
Perioperative Blood Transfusions and Prognosis in Patients with Curatively Resected Locally Advanced Gastric Cancer.
- Published in:
- Oncology, 1995, v. 52, n. 2, p. 170, doi. 10.1159/000227452
- By:
- Publication type:
- Article
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1532, doi. 10.1038/mt.2015.109
- By:
- Publication type:
- Article
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 389, doi. 10.1159/000535338
- By:
- Publication type:
- Article
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 522, doi. 10.1159/000537915
- By:
- Publication type:
- Article
Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
- By:
- Publication type:
- Article
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 38, doi. 10.1159/000519867
- By:
- Publication type:
- Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
- By:
- Publication type:
- Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2).
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 451, doi. 10.1159/000516605
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 440, doi. 10.1159/000506946
- By:
- Publication type:
- Article
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 16, p. 6986, doi. 10.1002/cam4.2570
- By:
- Publication type:
- Article
Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51981-5
- By:
- Publication type:
- Article
The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.792340
- By:
- Publication type:
- Article
α‐FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 6, p. 1043, doi. 10.1002/ijc.34799
- By:
- Publication type:
- Article
The life-sustaining treatments among cancer patients at end of life and the caregiver's experience and perspectives.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 73, doi. 10.1159/000368071
- By:
- Publication type:
- Article